At day 7, global ischemia-induced NLRP3 inflammasome activation (Figure 3A–E), as evidenced by an increase in the expression of NLRP3, and IL-1β (Figure 3A,H) in the hippocampus compared to Sham controls. The gene discussed is IL1B; the disease is ischemia.